- Home
- MCRI vs CERT Comparison
MCRI vs CERT Comparison
Compare MCRI & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRI
- CERT
- Stock Information
- Founded
- MCRI 1972
- CERT 2008
- Country
- MCRI United States
- CERT United States
- Employees
- MCRI N/A
- CERT N/A
- Industry
- MCRI Hotels/Resorts
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- MCRI Consumer Discretionary
- CERT Technology
- Exchange
- MCRI Nasdaq
- CERT Nasdaq
- Market Cap
- MCRI 1.6B
- CERT 1.8B
- IPO Year
- MCRI 1993
- CERT 2020
- Fundamental
- Price
- MCRI $84.05
- CERT $11.66
- Analyst Decision
- MCRI Hold
- CERT Buy
- Analyst Count
- MCRI 5
- CERT 7
- Target Price
- MCRI $84.00
- CERT $15.92
- AVG Volume (30 Days)
- MCRI 104.2K
- CERT 1.0M
- Earning Date
- MCRI 02-12-2025
- CERT 02-27-2025
- Dividend Yield
- MCRI 1.43%
- CERT N/A
- EPS Growth
- MCRI 2.59
- CERT N/A
- EPS
- MCRI 4.52
- CERT N/A
- Revenue
- MCRI $515,859,000.00
- CERT $372,797,000.00
- Revenue This Year
- MCRI $5.08
- CERT $10.20
- Revenue Next Year
- MCRI $1.73
- CERT $10.01
- P/E Ratio
- MCRI $18.58
- CERT N/A
- Revenue Growth
- MCRI 4.46
- CERT 5.62
- 52 Week Low
- MCRI $64.50
- CERT $9.41
- 52 Week High
- MCRI $89.06
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- MCRI 63.46
- CERT 57.94
- Support Level
- MCRI $77.17
- CERT $10.46
- Resistance Level
- MCRI $79.22
- CERT $12.21
- Average True Range (ATR)
- MCRI 1.47
- CERT 0.57
- MACD
- MCRI 0.78
- CERT 0.09
- Stochastic Oscillator
- MCRI 89.49
- CERT 71.20
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.